RxDoctor Payments Data

Shirly Solouki, MD

Urogynecology and Reconstructive Pelvic Surgery · New Brunswick, NJNPI 1053756197

Payments from drug & device makers

What this record shows

12 manufacturers reported payments, led by Coloplast at 25.8% of the total. Reporting peaked in 2024 at $1,438 and has fallen 79.1% since, to $301 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in NJ, where the typical reported total is $3,953.

$3,529in general payments, 2019–2025

Across 45 payments — averaging $78.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$911
  • Intuitive Surgical$774
  • Bluewind Medical$521
  • Contura, Inc.$494
  • Axonics, Inc.$345
  • Medtronic$165
  • plus $319 from 6 others

What the payments were for

  • Travel & lodging$1,70948%
  • Food & beverage$1,82052%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,529 in reported general payments places this provider in the 45th percentile of 35 urogynecology and reconstructive pelvic surgery providers in New Jersey.

See all urogynecology and reconstructive pelvic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$56,439
Medicare patients
147
Services billed
581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron198$117,302
GemtesaVibegron67$43,811
Estradiol245$17,856
PremarinEstrogens, Conjugated11$4,661
Trospium Chloride ErTrospium Chloride27$3,856
Methenamine Hippurate47$2,877
Trospium Chloride25$1,449
Clobetasol Propionate13$829
Oxybutynin Chloride ErOxybutynin Chloride17$252
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$242
Triamcinolone Acetonide18$153
Amitriptyline Hcl14$48
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$47
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$42

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in New Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →